The article highlights the devastating impact of long COVID on individuals like Erica Hayes, who has struggled with chronic symptoms since her initial infection in November 2020. Hayes, representative of the estimated 17 million adults suffering from the condition, faces challenges such as extreme fatigue, brain fog, and unexplained physical ailments. Despite significant federal funding for long COVID research, no effective treatments have emerged, leading to frustration among patients. Advocacy leaders, like Meighan Stone, express disappointment at the lack of FDA-approved drugs, emphasizing the urgent need for effective interventions for long COVID patients.
I've had multiple doctors look at it and tell me they don't know what's going on, Hayes said about her tongue.
It's unconscionable that more than four years since this began, we still don't have one FDA-approved drug, said Meighan Stone, executive director of the Long COVID Campaign.
Collection
[
|
...
]